These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15485491)

  • 1. Evaluation of 5-(2-(4-pyridinyl)vinyl)-6-chloro-3-(1-methyl-2-(S)-pyrrolidinylmethoxy)pyridine and its analogues as PET radioligands for imaging nicotinic acetylcholine receptors.
    Brown L; Chefer S; Pavlova O; Vaupel DB; Koren AO; Kimes AS; Horti AG; Mukhin AG
    J Neurochem; 2004 Nov; 91(3):600-12. PubMed ID: 15485491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of a novel series of 2-chloro-5-((1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl)pyridine analogues as potential positron emission tomography imaging agents for nicotinic acetylcholine receptors.
    Brown LL; Kulkarni S; Pavlova OA; Koren AO; Mukhin AG; Newman AH; Horti AG
    J Med Chem; 2002 Jun; 45(13):2841-9. PubMed ID: 12061886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
    Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
    J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIDA522131, a new radioligand for imaging extrathalamic nicotinic acetylcholine receptors: in vitro and in vivo evaluation.
    Chefer SI; Pavlova OA; Zhang Y; Vaupel DB; Kimes AS; Horti AG; Stein E; Mukhin AG
    J Neurochem; 2008 Jan; 104(2):306-15. PubMed ID: 17986233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosynthesis of 5-(2-(4-pyridinyl)vinyl)-6-chloro-3-(1-[(11)C]methyl-2-(S)-pyrrolidinylmethoxy)pyridine, a high affinity ligand for studying nicotinic acetylcholine receptors by positron emission tomography.
    Brown LL; Pavlova O; Mukhin A; Kimes AS; Horti AG
    Bioorg Med Chem; 2001 Nov; 9(11):3055-8. PubMed ID: 11597489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
    Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
    Doll F; Dolci L; Valette H; Hinnen F; Vaufrey F; Guenther I; Fuseau C; Coulon C; Bottlaender M; Crouzel C
    J Med Chem; 1999 Jun; 42(12):2251-9. PubMed ID: 10377231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Chloro-3-(((1-[11C]methyl)-2-(S)-pyrrolidinyl)methoxy)-5-(2-fluoropyridin-4-yl)pyridine ([11C]JHU85270), a potent ligand for nicotinic acetylcholine receptor imaging by positron emission tomography.
    Gao Y; Ravert HT; Holt D; Dannals RF; Horti AG
    Appl Radiat Isot; 2007 Aug; 65(8):947-51. PubMed ID: 17566748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivatives of (-)-7-methyl-2-(5-(pyridinyl)pyridin-3-yl)-7-azabicyclo[2.2.1]heptane are potential ligands for positron emission tomography imaging of extrathalamic nicotinic acetylcholine receptors.
    Gao Y; Horti AG; Kuwabara H; Ravert HT; Hilton J; Holt DP; Kumar A; Alexander M; Endres CJ; Wong DF; Dannals RF
    J Med Chem; 2007 Aug; 50(16):3814-24. PubMed ID: 17629263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-ZW-104: a new radioligand for imaging neuronal nicotinic acetylcholine receptors--in vitro binding properties and PET studies in baboons.
    Valette H; Xiao Y; Peyronneau MA; Damont A; Kozikowski AP; Wei ZL; Kassiou M; Kellar KJ; Dollé F; Bottlaender M
    J Nucl Med; 2009 Aug; 50(8):1349-55. PubMed ID: 19652217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]FPhEP and [18F]F2PhEP, two new epibatidine-based radioligands: evaluation for imaging nicotinic acetylcholine receptors in baboon brain.
    Valette H; Dollé F; Saba W; Roger G; Hinnen F; Coulon C; Ottaviani M; Syrota A; Bottlaender M
    Synapse; 2007 Sep; 61(9):764-70. PubMed ID: 17568410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 5-(11)C-methyl-A-85380 as an imaging agent for PET investigations of brain nicotinic acetylcholine receptors.
    Iida Y; Ogawa M; Ueda M; Tominaga A; Kawashima H; Magata Y; Nishiyama S; Tsukada H; Mukai T; Saji H
    J Nucl Med; 2004 May; 45(5):878-84. PubMed ID: 15136639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation in rats and primates of [11C]-mecamylamine, a potential nicotinic acetylcholine receptor radioligand for positron emission tomography.
    Sobrio F; Debruyne D; Dhilly M; Chazalviel L; Camsonne R; Kakiuchi T; Tsukada H; Barré L
    Neurochem Int; 2005 May; 46(6):479-88. PubMed ID: 15769550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of new imaging agent for central nicotinic acetylcholine receptor α7 subtype.
    Ogawa M; Nishiyama S; Tsukada H; Hatano K; Fuchigami T; Yamaguchi H; Matsushima Y; Ito K; Magata Y
    Nucl Med Biol; 2010 Apr; 37(3):347-55. PubMed ID: 20346874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kinetics.
    Kuwabara H; Wong DF; Gao Y; Valentine H; Holt DP; Ravert HT; Dannals RF; Horti AG
    J Nucl Med; 2012 Jan; 53(1):121-9. PubMed ID: 22173841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.
    Gallezot JD; Bottlaender M; Grégoire MC; Roumenov D; Deverre JR; Coulon C; Ottaviani M; Dollé F; Syrota A; Valette H
    J Nucl Med; 2005 Feb; 46(2):240-7. PubMed ID: 15695782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and radiosynthesis of [(18)F]FPhEP, a novel alpha(4)beta(2)-selective, epibatidine-based antagonist for PET imaging of nicotinic acetylcholine receptors.
    Roger G; Saba W; Valette H; Hinnen F; Coulon C; Ottaviani M; Bottlaender M; Dollé F
    Bioorg Med Chem; 2006 Jun; 14(11):3848-58. PubMed ID: 16455259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping alpha7 nicotinic receptors by positron emission tomography.
    Toyohara J; Sakata M; Wu J; Ishikawa M; Oda K; Ishii K; Iyo M; Hashimoto K; Ishiwata K
    Ann Nucl Med; 2009 May; 23(3):301-9. PubMed ID: 19337782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Pyridyl ethers as SPECT radioligands for imaging nicotinic acetylcholine receptors.
    Henderson DJ; Eberl S; Thomson S; Smith A; Allan RD; Fulham MJ; Loiacono R; Kassiou M
    Appl Radiat Isot; 2004 May; 60(5):669-76. PubMed ID: 15082045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements.
    Ettrup A; Mikkelsen JD; Lehel S; Madsen J; Nielsen EØ; Palner M; Timmermann DB; Peters D; Knudsen GM
    J Nucl Med; 2011 Sep; 52(9):1449-56. PubMed ID: 21828113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.